These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 2934750

  • 1. Mechanistic studies on DOM as a discriminative stimulus.
    Glennon RA, Hauck AE.
    Pharmacol Biochem Behav; 1985 Dec; 23(6):937-41. PubMed ID: 2934750
    [Abstract] [Full Text] [Related]

  • 2. Discriminative stimulus properties of the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH DPAT).
    Glennon RA.
    Pharmacol Biochem Behav; 1986 Jul; 25(1):135-9. PubMed ID: 2944129
    [Abstract] [Full Text] [Related]

  • 3. Discriminative stimulus properties of the serotonergic agent 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI).
    Glennon RA.
    Life Sci; 1986 Sep 01; 39(9):825-30. PubMed ID: 2943960
    [Abstract] [Full Text] [Related]

  • 4. Effect of 8-hydroxy-2-(N,N-di-n-propylamino)tetralin and MDMA on the discriminative stimulus effects of the classical hallucinogen DOM in rats.
    Khorana N, Young R, Glennon RA.
    Pharmacol Biochem Behav; 2009 Jan 01; 91(3):385-92. PubMed ID: 18778728
    [Abstract] [Full Text] [Related]

  • 5. Stimulus properties of tiflucarbine: a novel antidepressant agent.
    Glennon RA, De Vry J, Spencer DG, Glaser T.
    Pharmacol Biochem Behav; 1990 Dec 01; 37(4):769-71. PubMed ID: 2151199
    [Abstract] [Full Text] [Related]

  • 6. Discriminative stimulus properties of flesinoxan.
    Ybema CE, Slangen JL, Olivier B, Mos J.
    Pharmacol Biochem Behav; 1990 Apr 01; 35(4):781-4. PubMed ID: 2140607
    [Abstract] [Full Text] [Related]

  • 7. Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
    Glennon RA, Young R, Rosecrans JA.
    Eur J Pharmacol; 1983 Jul 22; 91(2-3):189-96. PubMed ID: 6617740
    [Abstract] [Full Text] [Related]

  • 8. Discriminative stimulus properties of DOM and several molecular modifications.
    Glennon RA, Young R, Rosecrans JA.
    Pharmacol Biochem Behav; 1982 Apr 22; 16(4):553-6. PubMed ID: 7071088
    [Abstract] [Full Text] [Related]

  • 9. Discriminative stimulus properties of MDA analogs.
    Glennon RA, Young R, Rosecrans JA, Anderson GM.
    Biol Psychiatry; 1982 Jul 22; 17(7):807-14. PubMed ID: 6126227
    [Abstract] [Full Text] [Related]

  • 10. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 11. Discriminative stimulus properties of the serotonergic compound eltoprazine.
    Ybema CE, Slangen JL, Olivier B, Mos J.
    J Pharmacol Exp Ther; 1992 Mar 06; 260(3):1045-51. PubMed ID: 1532031
    [Abstract] [Full Text] [Related]

  • 12. The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors.
    Winter JC, Filipink RA, Timineri D, Helsley SE, Rabin RA.
    Pharmacol Biochem Behav; 2000 Jan 01; 65(1):75-82. PubMed ID: 10638639
    [Abstract] [Full Text] [Related]

  • 13. Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), ketanserin, and (R)-(+)-{alpha}-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-pipidinemethanol (MDL100907) in rats.
    Li JX, Unzeitig A, Javors MA, Rice KC, Koek W, France CP.
    J Pharmacol Exp Ther; 2009 Nov 01; 331(2):671-9. PubMed ID: 19687292
    [Abstract] [Full Text] [Related]

  • 14. Involvement of 5-HT receptor subtypes in the discriminative stimulus properties of mescaline.
    Appel JB, Callahan PM.
    Eur J Pharmacol; 1989 Jan 02; 159(1):41-6. PubMed ID: 2707301
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the discriminative stimulus properties of R-2,5-dimethoxy-4-methylamphetamine (R-DOM) and S-amphetamine in the rat.
    Tilson HA, Baker TG, Gylys JA.
    Psychopharmacologia; 1975 Nov 21; 44(3):225-8. PubMed ID: 1208758
    [Abstract] [Full Text] [Related]

  • 16. Interactions of clozapine with the stimulus effects of DOM and LSD.
    Palumbo PA, Winter JC.
    Pharmacol Biochem Behav; 1994 Sep 21; 49(1):115-20. PubMed ID: 7816860
    [Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 21; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 18. DOM-stimulus generalization to LSD and other hallucinogenic indolealkylamines.
    Glennon RA, Young R, Jacyno JM, Slusher M, Rosecrans JA.
    Eur J Pharmacol; 1983 Jan 21; 86(3-4):453-9. PubMed ID: 6572591
    [Abstract] [Full Text] [Related]

  • 19. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
    Glennon RA, Rosecrans JA, Young R, Gaines J.
    Life Sci; 1979 Mar 12; 24(11):993-7. PubMed ID: 286864
    [No Abstract] [Full Text] [Related]

  • 20. Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.
    Li JX, Koek W, Rice KC, France CP.
    J Pharmacol Exp Ther; 2010 Apr 12; 333(1):244-52. PubMed ID: 20053932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.